1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, July 2016 (p20)

Biotechnology Analysis & Statistics in the United States, July 2016 (p20)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

571-600 of about 2400 reports

Purchase Reports From Reputable Market Research Publishers

Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2016

Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2016’, provides in depth analysis ...

  • Industries : Pathology, Pharmaceutical, Therapy
  • Countries : United States
Maternal Embryonic Leucine Zipper Kinase (Protein Kinase Eg3 or Tyrosine Protein Kinase MELK or Protein Kinase PK38 or MELK or EC 2.7.11.1) - Pipeline Review, H2 2016

Maternal Embryonic Leucine Zipper Kinase (Protein Kinase Eg3 or Tyrosine Protein Kinase MELK or Protein Kinase PK38 or MELK or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Maternal Embryonic Leucine Zipper Kinase (Protein Kinase Eg3 or Tyrosine Protein Kinase MELK or Protein Kinase PK38 or MELK or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Cancer, Pathology, Biopharmaceutical
  • Countries : United States
Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2016

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States, World
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H2 2016

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline ...

  • Industries : Biopharmaceutical, Biotechnology, Therapy, Biological Therapy
  • Countries : United States, World
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2016

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • July 2016
  • by Global Markets Direct

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H2 2016’, provides an overview of the Chemotherapy ...

  • Industries : Therapy, Oncology, Biological Therapy
  • Countries : World, United States, China
Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016

Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016’, provides in depth analysis on Human ...

  • Industries : Biopharmaceutical, Biological Therapy, Biotechnology, Therapy, Pathology, Cancer, Pharmaceutical
  • Countries : United States
Hypoxia Inducible Factor 1 Alpha (ARNT Interacting Protein or Basic Helix Loop Helix PAS Protein MOP1 or Class E Basic Helix Loop Helix Protein 78 or Member Of PAS Protein 1 or PAS Domain Containing Protein 8 or HIF1A) - Pipeline Review, H2 2016

Hypoxia Inducible Factor 1 Alpha (ARNT Interacting Protein or Basic Helix Loop Helix PAS Protein MOP1 or Class E Basic Helix Loop Helix Protein 78 or Member Of PAS Protein 1 or PAS Domain Containing Protein 8 or HIF1A) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Hypoxia Inducible Factor 1 Alpha (ARNT Interacting Protein or Basic Helix Loop Helix PAS Protein MOP1 or Class E Basic Helix Loop Helix Protein 78 or Member Of PAS Protein 1 or PAS Domain Containing Protein ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2016

Acute Respiratory Distress Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • July 2016
  • by Global Markets Direct

Acute Respiratory Distress Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Acute Respiratory Distress Syndrome - Pipeline Review, H2 2016’, provides an overview of the Acute ...

  • Industries : Pathology, Biological Therapy, Therapy, Pharmaceutical
  • Countries : World, United States, Germany, Europe, Japan
MacroGenics, Inc. - Product Pipeline Review - 2016

MacroGenics, Inc. - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • July 2016
  • by Global Markets Direct

MacroGenics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘MacroGenics, Inc. - Product Pipeline Review - 2016’, provides an overview of the MacroGenics, Inc.’s pharmaceutical ...

  • Industries : Cancer, Pathology, Research and Development
  • Countries : United States, World
Myasthenia Gravis - Pipeline Review, H2 2016

Myasthenia Gravis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • July 2016
  • by Global Markets Direct

Myasthenia Gravis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H2 2016’, provides an overview of the Myasthenia Gravis pipeline landscape. The ...

  • Industries : Pathology, Mental Health, Therapy
  • Countries : United States
BIND Therapeutics Inc

BIND Therapeutics Inc

  • $ 99
  • Company report
  • July 2016
  • by Wright Investors' Service

A textual analysis of the financial results for BIND Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : United States
Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc.

  • $ 99
  • Company report
  • July 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Hemispherx Biopharma, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Countries : United States
Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • July 2016
  • by Global Data

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World, United States
Biotechnology in the US - Industry Market Research Report

Biotechnology in the US - Industry Market Research Report

  • $ 1020
  • Industry report
  • July 2016
  • by Ibisworld

Gene therapy: Growing demand for medical applications will support revenue Biotechnology in the US The Biotechnology industry is growing quickly, with revenue increases over the past five years driven ...

  • Industries : Biotechnology
  • Countries : United States
Aeglea BioTherapeutics, Inc. (AGLE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aeglea BioTherapeutics, Inc. (AGLE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary Aeglea BioTherapeutics, Inc. (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops engineered human enzymes and companion diagnostics ...

  • Countries : United States
Aduro BioTech, Inc. (ADRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aduro BioTech, Inc. (ADRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary Aduro BioTech, Inc. (Aduro BioTech) is a clinical-stage immunotherapy company that focuses on the discovery, development and commercialization of therapies for the treatment of cancer. The company ...

  • Industries : Biotechnology
  • Countries : United States
Alder Biopharmaceuticals Inc. (ALDR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alder Biopharmaceuticals Inc. (ALDR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary Alder Biopharmaceuticals Inc. (Alder) is a biotechnology company that develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune ...

  • Industries : Biopharmaceutical
  • Countries : United States
U.S. Stem Cell, Inc. (USRM) - Medical Equipment - Deals and Alliances Profile

U.S. Stem Cell, Inc. (USRM) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary U.S. Stem cell, Inc., (formerly Bioheart, Inc.) is a biotechnology company which focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs ...

  • Industries : Biological Therapy
  • Countries : United States
Kane Biotech Inc. (KNE) - Medical Equipment - Deals and Alliances Profile

Kane Biotech Inc. (KNE) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary Kane Biotech Inc. (Kane Biotech) is a biotechnology company that develops and commercializes products that prevent and remove microbial biofilms. The company uses patent protected technology based ...

  • Industries : Biotechnology
  • Countries : United States
WaferGen Biosystems, Inc. (WGBS) - Medical Equipment - Deals and Alliances Profile

WaferGen Biosystems, Inc. (WGBS) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary WaferGen Biosystems, Inc. (WaferGen) is a biotechnology Company which develops, manufactures and sells systems for genomic technology solutions for single-cell analysis and clinical research. The ...

  • Industries : Biotechnology
  • Countries : United States
IntegraGen SA (ALINT) - Product Pipeline Analysis, 2016 Update

IntegraGen SA (ALINT) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • July 2016
  • by Global Data

Summary IntegraGen SA (IntegraGen) is a biotechnology company that offers clinical genomic services to academic researchers and life sciences companies. The company provides advanced bioinformatics and ...

  • Industries : Cancer, Pathology, Genomics, Therapy
  • Countries : France, United States
Quanterix Corporation - Product Pipeline Analysis, 2016 Update

Quanterix Corporation - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • July 2016
  • by Global Data

Summary Quanterix Corporation (Quanterix) is a medical device manufacturer that develops ultra-sensitive diagnostic platform for measuring individual proteins. The company’s products include simoa HD1 ...

  • Industries : In Vitro Diagnostics
  • Countries : United States
SomaLogic, Inc. - Product Pipeline Analysis, 2016 Update

SomaLogic, Inc. - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • July 2016
  • by Global Data

Summary SomaLogic, Inc. (SomaLogic) is a life science tools and clinical diagnostics company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The ...

  • Industries : Pathology, Cancer, Mental Health
  • Countries : United States
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • July 2016
  • by Global Markets Direct

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016’, provides an overview of the Systemic Sclerosis ...

  • Industries : Pathology, Chronic Disease, Healthcare, Therapy
  • Countries : United States
Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • July 2016
  • by Global Markets Direct

Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Alnylam Pharmaceuticals, Inc. - Product Pipeline Review, 2016’, provides an overview of the Alnylam ...

  • Industries : Pharmaceutical, Research and Development, Pathology
  • Countries : United States
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Pipeline Review, H2 2016

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Serine/Threonine Protein Kinase Pim 2 (Pim ...

  • Industries : Biopharmaceutical, Cancer, Pathology, Pharmaceutical
  • Countries : United States, World
Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeli

Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeli

  • $ 3500
  • Industry report
  • July 2016
  • by Global Markets Direct

Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR ...

  • Industries : Cancer, Pathology, Pharmaceutical, Therapy
  • Countries : United States
Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2016

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) ...

  • Industries : Biopharmaceutical, Pathology, Biological Therapy, Biotechnology
  • Countries : United States
High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) - Pipeline

High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) - Pipeline

  • $ 3500
  • Industry report
  • July 2016
  • by Global Markets Direct

High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States
Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Pipeline Review, H2 2016

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 ...

  • Industries : Biopharmaceutical, Cancer, Pathology
  • Countries : United States, World
About 12000 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • December 2016
    4 pages
  • Cancer  

    Protein  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.